Agf Investments Inc. Natera, Inc. Transaction History

Agf Investments Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$30.32 - $91.33 $4.1 Million - $12.3 Million	-135,127 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$86.26 - $119.0 $1,466 - $2,023	17 Added 0.01%	135,127 $12.6 Million
Q3 2021 Nov 10, 2021	SELL	$100.17 - $126.36 $6.51 Million - $8.21 Million	-64,963 Reduced 32.47%	135,110 $15.1 Million
Q2 2021 Aug 10, 2021	BUY	$86.05 - $119.72 $2.58 Million - $3.59 Million	30,000 Added 17.64%	200,073 $22.7 Million
Q1 2021 May 14, 2021	BUY	$91.47 - $124.36 $6,677 - $9,078	73 Added 0.04%	170,073 $17.3 Million
Q2 2019 Jul 30, 2019	BUY	$17.75 - $27.58 $2.13 Million - $3.31 Million	120,000 Added 240.0%	170,000 $4.69 Million
Q1 2019 May 10, 2019	BUY	$11.34 - $20.62 $567,000 - $1.03 Million	50,000 New	50,000 $1.03 Million

527

118M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.7B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.